Cyanotech (Cyanotech) Risk Assessment

View and export this data going back to 1993. Start your Free Trial

What is Cyanotech Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Cyanotech is: High Risk: High uncertainty.

Competitive Comparison of Cyanotech's Risk Assessment

For the Packaged Foods subindustry, Cyanotech's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyanotech's Risk Assessment Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cyanotech's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Cyanotech's Risk Assessment falls into.

Cyanotech (OTCPK:CYAN) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Cyanotech Risk Assessment Related Terms

Thank you for viewing the detailed overview of Cyanotech's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyanotech (Cyanotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cyanotech Corp (OTCPK:CYAN) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, HI, USA, 96740

Website

https://www.cyanotech.com

Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company's products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. It derives maximum revenue from the Packaged product and geographically from the United States.

Executives

Kakuk Collette Nicole	officer: Chief Strategic Comml Officer	73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Michael A / Davis	director, 10 percent owner	1621 JUANITA LANE, TIBURON CA 94920
Angela May Mcelwee	director	73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Charles Jason Hartmann	officer: VP, Sales & Marketing	73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Glenn Jensen	officer: VP-Operations	73-4460 QUEEN KAAHUMANU HWY #102, KAILUA-KONA HI 96740
Jennifer M. Johansen	officer: VP of Quality	73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Walter Bennett Menzel	director	45 MOUNT TIBURON ROAD, TIBURON CA 94920
Felicia I Ladin	officer: CFO, VP Fin & Admin, Treasurer	26 CORPORATE CIRCLE, ALBANY NY 12203
Matthew Keith Custer	officer: Vice President, Gen Mgr	73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Amy Beth Nordin	officer: VP, HR, Secretary	73-4460 QUEEN KAAHUMANU HWY. SUITE 102, KAILUA-KONA HI 96740
Brian Brett Orlopp	officer: CFO, VP, Treasurer, Secretary	73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA CA 96740
Gerald J Watts	officer: COO	2530 RED HILL AVE, SANTA ANA CA 92705
Mawae Morton	officer: President	7473 MAKA'A STREET, HONOLULU HI 96825
Nancy E Katz	director	CALYPTE BIOMEDICAL CORP, 1265 HARBOR BAY PKWY, ALAHEDA CA 94502
David M Mulder	director	21771 CALATRAVA, MISSION VIEJO CA 92692